|  | Drug susceptibility testing result available* | Total TB positive (any type) | |||
---|---|---|---|---|---|---|
Characteristics | Goroka n = 56 n (%) | Alotau n = 66 n (%) | Madang n = 90 n (%) | Total n = 212 n (%) | All sites n = 449 n(%) | |
Sex | Â | Â | Â | Â | Â | |
 | Male | 32 (57.1) | 28 (42.4) | 43 (47.8) | 103 (48.6) | 221 (49.22) |
 | Female | 24 (42.9) | 38 (57.6) | 47 (52.2) | 109 (51.4) | 228 (50.78) |
Median age [IQR] | 30 [25-40] | 29 [24-42] | 30 [24-40] | 30 [24-40] | 30 [25-42] | |
Age group | Â | Â | Â | Â | Â | |
 | 15-24: | 13 (23.2) | 19 (28.8) | 27 (30.0) | 59 (27.8) | 110 (24.5) |
25-34: | 19 (33.9) | 23 (34.9) | 31 (34.4) | 73 (34.4) | 157 (35.0) | |
35-44: | 12 (21.5) | 9 (13.6) | 16 (17.8) | 37 (17.5) | 76 (16.9) | |
45-54: | 7 (12.5) | 8 (12.1) | 9 (10.0) | 24 (11.3) | 51 (11.4) | |
55-64: | 4 (7.1) | 4 (6.1) | 5 (5.6) | 13 (6.1) | 40 (8.9) | |
>64: | 0 | 2 (3.0) | 1 (1.1) | 3 (1.4) | 11 (2.4) | |
 | missing: | 1 (1.8) | 1 (1.5) | 1 (1.1) | 3 (1.4) | 4 (0.9) |
Smear result | Â | Â | Â | Â | Â | |
 | Smear positive | 55 (98.2) | 62 (93.9) | 90 (100) | 207 (97.6) | 280 (62.4) |
 | Smear negative | 1 (1.8) | 4 (6.1) | 0 | 5 (2.4) | 116 (25.8) |
HIV | Â | Â | Â | Â | Â | |
 | HIV+ | 12 (21.4) | 1 (1.5) | 3 (3.3) | 16 (7.5) | 36 (8.0) |
 | HIV- | 23 (41.1) | 12 (18.2) | 43 (47.8) | 78 (36.8) | 140 (31.2) |
 | HIV unknown | 21 (37.5) | 53 (80.3) | 44 (48.9) | 118 (55.7) | 273 (60.8) |
Region of origin | Â | Â | Â | Â | Â | |
 | Highlands | 25 (44.6) | 0 | 3 (3.3) | 28 (13.2) | 71 (15.8) |
Coast | 4 (7.2) | 23 (34.9) | 84 (93.3) | 111 (52.3) | 171 (38.1) | |
Other country | 0 | 0 | 1 (1.1) | 1 (0.5) | 1 (0.2) | |
Unknown | 27 (48.2) | 43 (65.1) | 2 (2.2) | 72 (34.0) | 206 (45.9) | |
History of TB treatment | Â | Â | Â | Â | Â | |
 | No | 50 (89.3) | 42 (63.6) | 75 (83.3) | 167 (78.8) | 355 (79.1) |
Yes | 2 (3.6) | 5 (7.6) | 11 (12.2) | 18 (8.5) | 50 (11.4) | |
Unknown | 4 (7.1) | 19 (28.8) | 4 (4.5) | 27 (12.7) | 44 (9.8) |